| 000 | 01647 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517144316.0 | ||
| 264 | 0 | _c20170605 | |
| 008 | 201706s 0 0 eng d | ||
| 022 | _a1468-1331 | ||
| 024 | 7 |
_a10.1111/ene.13272 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHavrdova, E | |
| 245 | 0 | 0 |
_aEffect of delayed-release dimethyl fumarate on no evidence of disease activity in relapsing-remitting multiple sclerosis: integrated analysis of the phase III DEFINE and CONFIRM studies. _h[electronic resource] |
| 260 |
_bEuropean journal of neurology _cMay 2017 |
||
| 300 |
_a726-733 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 |
_aDimethyl Fumarate _xadministration & dosage |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlatiramer Acetate _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aMagnetic Resonance Imaging _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Sclerosis, Relapsing-Remitting _xdiagnostic imaging |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aGiovannoni, G | |
| 700 | 1 | _aGold, R | |
| 700 | 1 | _aFox, R J | |
| 700 | 1 | _aKappos, L | |
| 700 | 1 | _aPhillips, J Theodore | |
| 700 | 1 | _aOkwuokenye, M | |
| 700 | 1 | _aMarantz, J L | |
| 773 | 0 |
_tEuropean journal of neurology _gvol. 24 _gno. 5 _gp. 726-733 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/ene.13272 _zAvailable from publisher's website |
| 999 |
_c27001959 _d27001959 |
||